High-dose cytosine - Arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma

Journal of Acquired Immune Deficiency Syndromes

Volumn 28, Issue 5, 2001, Pages 416-421

  Bi, Jia ^a   Espina, Byron M ^a   Tulpule, Anil ^a   Boswell, William ^a   Levine, Alexandra M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

AIDS lymphoma; Lymphoma; Treatment of relapsed lymphoma

Indexed keywords

CISPLATIN; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; METHYLPREDNISOLONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; FEVER; HUMAN; MALE; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SALVAGE THERAPY;

EID: 0035894065     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200112150-00002     Document Type: Article

References (29)

1. AIDS-associated non-Hodgkin's lymphoma
2. Acquired immunodeficiency syndrome-related lymphoma
3. Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States
4. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: The changing face of AIDS
5. Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation, and public health burden
6. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
7. AIDS across Europe, 1994-1998: The EuroSIDA study
8. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults
9. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
10. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy
11. Low dose chemotherapy with central nervous system prophylaxis and azidothymidine maintenance in AIDS-related lymphoma: A prospective multi-institutional trial
12. Low dose compared with standard dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection
13. Treatment of HIV related non-Hodgkin's lymphoma adapted to prognostic factors
14. Second-line chemotherapy (CT) with CDE (cyclophosphamide, doxorubicin, etoposide) in patients (pts) with resistant human immunodeficiency virus-related non-Hodgkin's lymphoma (HIV-NHL)
15. Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: Results from a multicenter phase II trial
16. Second line chemotherapy in HIV related non-Hodgkin's lymphoma
17. Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation
18. DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma
19. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)
20. Intensive chemotherapy with hematopoietic cell transplantation alter ESHAP therapy for relapsed or refractory non-Hodgkin's lymphoma: Results of a single-center study of 65 patients
21. ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma: Taiwan experience
22. Report of the committee on Hodgkin's disease staging classification
23. ESHAP - An effective chemotherapy regimen in refractory and relapsed lymphoma: A 4-year follow-up study
24. Nonparametric estimation from incomplete observations
25. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastin in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma
26. Phase II trial of infusional cyclophosphamide, doxorubicin and etoposide (CDE) in HIV associated non-Hodgkin's lymphoma: An Eastern Cooperative Oncology Group trial (E1494)
27. Dose-adjusted EPOCH chemotherapy with suspension of antiretroviral therapy for HIV-associated non-Hodgkin's lymphoma
28. Results of recent salvage regimens for lymphoma and Hodgkin's disease
29. Etoposide as single agent and in combination with cis-platinum for malignant lymphomas